汉中胃方面的体检(铁门关面体检 多少钱) (今日更新中)

KUALA LUMPUR, Feb. 3 (Xinhua) -- Malaysian Prime Minister Najib Razak wishes all Chinese in the world a happy Chinese New Year on Thursday in an exclusive interview with Xinhua News Agency at his official residence in Federal Administrative Center Putrajaya."I would like to wish all Chinese in the world, wherever they are at any part of the world, a very happy Chinese New Year through Xinhua News Agency,"Najib said. "I hope that this new lunar calendar year, the year of the Rabbit will bring much prosperity and will be a successful and productive year."Najib also noted the 36-year-old special ties between Malaysia and China - a relationship which was first established by his father Abdul Razak, the second prime minister of Malaysia.He stressed that Malaysia is determined to forge closer diplomatic relations with China in years ahead."The relationship between Malaysia and China is a very warm and strong relationship that was established way back in 1974, we were the first Southeast Asian to have established diplomatic relations with China," Najib said."Ever since that historic occasion, the relationship between the tow countries has developed from strength to strength and leaps and bounds and today it's the most important relationship that we have," Najib said. "I hope this relationship will bring much benefit to both Malaysia and China, I wish it can be developed further and strengthen and deepen this important relationship."The prime minister had his Thursday occupied, attending numerous Spring Festival Open House, including the one held by the Malaysian Chinese Association (MCA) - the largest party that represents the ethnic Chinese in the country's ruling coalition.Thousands attended the open house event at the party's headquarters, many of whom were tourists.Malaysian leaders, ambassadors and attaches from foreign embassies were among the invited guests at the event.The Open House is a Malaysian tradition during celebrations where people open their doors to welcome guests and even strangers into their homes.He then held a live teleconference with Malaysians residing in seven cities in the world, including Guangzhou, China, and sent his greetings.About 26 percent of Malaysia's 27 million population are ethnic Chinese.

WASHINGTON, May 27 (Xinhua) -- Two U.S. astronauts conducted the fourth and final scheduled spacewalks for space shuttle Endeavour 's STS-134 mission on Friday morning, the U.S. National Aeronautics and Space Administration (NASA) announced.The seven-hour, 24-minute spacewalk completed by Mike Fincke and Greg Chamitoff at 7:39 a.m. EDT (1139 GMT) was the final spacewalk conducted by space shuttle astronauts before NASA turns over Endeavour and sister ships Discovery and Atlantis to museums. Space station crew will continue to make spacewalks for maintenance and repair tasks.At 5:02 a.m. (0902 GMT), Fincke and Chamitoff surpassed the 1, 000th hour astronauts and cosmonauts have spent spacewalking in support of space station assembly and maintenance. The milestone occurred four hours and 47 minutes into the spacewalk, the 159th in support of station assembly and maintenance, totaling 1,002 hours, 37 minutes.The astronauts completed their mission to stow the 50-foot-long boom on the station truss and work on some new installations to extend the space station's robotic arm. After that, shuttle commander Mark Kelly called Mission Control in Houston to mark the milestone -- after 12 years of efforts."Space station assembly is complete," Kelly said.It was the 248th spacewalk U.S. astronauts have conducted and the 118th from space station airlocks. Landing is scheduled for 2: 32 a.m. EDT (0632 GMT) on Wednesday at the Kennedy Space Center in Florida. Shuttle Atlantis is targeted to launch on July 8 for space shuttle's final flight.Endeavour lifted off on May 16 from the Kennedy Space Center in Florida, to deliver to the International Space Station a 2-billion- dollar, multinational particle detector known as the Alpha Magnetic Spectrometer (AMS).AMS, a particle physics detector, is designed to search for various types of unusual matter by measuring cosmic rays. Its experiments are designed to help researchers study the formation of the universe and search for evidence of dark matter, strange matter and antimatter.NASA's 30-year-old shuttle program is ending due to high operating costs. The Obama administration wants to spur private companies to get into the space taxi business, freeing NASA to focus on deep space exploration and new technology development.When the U.S. space shuttle program officially ends later this year, the Russian space program's Soyuz capsule will be the only method for transporting astronauts to and from the station.

LOS ANGELES, April 7 (Xinhua) -- Unrecycled energy-efficient bulbs release tons of mercury into the environment every year, raising an environmental concern, it was reported on Thursday.Demand for the energy-efficient lights -- the compact fluorescent light bulb (CFL) -- is growing as government mandates for energy-efficient lighting take effect, yet only about two percent of residential consumers and one-third of businesses recycle the new bulbs, the Los Angeles Times said, quoting the Association of Lighting and Mercury Recyclers (ALMR).Each CFL contains up to five milligrams of mercury, a potent neurotoxin that's on the worst-offending list of environmental contaminants, the report said.As a result, U.S. landfills are releasing more than four tons of mercury annually into the atmosphere and storm water runoff, the Journal of the Air and Waste Management Association said in a study published by the paper.The federal Clean Energy Act of 2007 established energy- efficiency standards for light bulbs that dimmed the future for old-fashioned incandescents, which don't meet those standards. Incandescents are to be phased out by 2014 in the U.S., and California passed even stricter rules, calling for store shelves to be cleared of them by 2013.The old-style bulbs are just too wasteful, converting to light only 10 percent of the energy they consume. The rest is squandered as heat.Sales of energy-efficient alternatives like CFLs, halogen bulbs and LEDs have been growing steadily, with the low-cost CFLs the biggest sellers, according to the paper.If every California household replaced five incandescent bulbs with CFLs, the move would save 6.18 billion kilowatt-hours and prevent the annual release of 2.26 million tons of heat-trapping carbon dioxide, according to the California Energy Commission. That 's equivalent to taking 414,000 cars off the road.But no federal law mandates recycling of household fluorescent lights. Federal rules exempt some businesses, based in part on the number of bulbs used, said Paul Abernathy, executive director of the ALMR, which is based in Napa, Calif.Several states, including California, Massachusetts, Maine, Vermont and Minnesota, do require that all households and businesses recycle fluorescents, the paper said.But the ALMR said compliance is low because of a lack of convenient drop-off options.

HONG KONG, March 18 (Xinhua) -- After over a year's efforts, scientists from Shanghai and Hong Kong announced on Friday that they have completed the whole genomic sequencing work of Isaria cicada, a rare herb highly valued in traditional Chinese medicine, which will help facilitate its further development in medical and nutrition fields.It is the first time that the whole genomic sequence of Isaria cicada has been released, said the scientists from Shanghai Institute of Bio-Asia Life Science and the Hong Kong University of Science and Technology (HKUST), who participated in the research.The result was announced at the International Biomedical Scientists and Biotechnology Forum 2011 held in the day at the Hong Kong Science Park.According to the result, the genomic size of Isaria cicada, a medicine traditionally used to treat children's diseases, is about one eightieth of human genome, containing about 16,000 genes.The tests that had been done proved that Isaria cicada, with many high-quality genes not recognized or used by human beings yet, has been deeply involved in important life processes like metabolism, providing new ways for further development of Isaria cicad in bio-medical area, said a scientist from HKUST.The genome map will also help accelerate the artificial cultivation of Isaria cicada, enhancing its medicine and nutrition value and making it available in a larger market, according to the scientist.

WASHINGTON, April 11 (Xinhua) -- In the first clinical trial of gene therapy for treatment of intractable pain, U.S. researchers from the University of Michigan's Department of Neurology observed that the treatment appears to be able to provide substantial pain relief.In a study published online in the Annals of Neurology and seen on Monday, the researchers showed that the novel agent NP2 is safe and well-tolerated. In addition, measures of pain in the treated patients suggested that NP2 may provide a substantial analgesic effect.NP2 is a gene transfer vector that expresses the naturally- occurring opioid peptide enkephalin. In preclinical work in animals, David Fink, chair of the Department of Neurology, and his coworkers had demonstrated that injection of NP2 into the skin reduces pain in models of pain caused by nerve damage, inflammation or cancer.In the clinical trial, 10 patients with unrelenting pain caused by cancer were injected with the gene transfer agent in the area of skin related to the location of pain."The concept underlying this therapeutic approach is that injection of NP2 into the skin results in uptake into the nervous system and the production and release of a pain-relieving chemical in a controlled site in the pain pathway," says Fink. "In the study, patients who received the low dose of vector showed little reduction in pain; patients receiving the higher doses showed a greater than 80 percent reduction in pain over the course of four weeks following treatment."Fink's laboratory has been working on the use of modified herpes simplex virus-based vectors that are taken up by sensory nerves following skin injection to develop therapies for diseases of the nervous system for more than 20 years. Patents related to this technology have been exclusively licensed by Diamyd Medical, a publicly-traded Swedish biotechnology company that sponsored the trial, and the human-grade vector NP2 was produced by Diamyd, Inc, the U.S. subsidiary of Diamyd Medical.A phase 2 trial to compare NP2 to a placebo control has already been initiated under sponsorship from Diamyd.

来源：资阳报